Idiopathic Pulmonary Fibrosis

Latest News in Idiopathic Pulmonary Fibrosis

August 22, 2024

Deciphering the role of oxidative stress genes in idiopathic pulmonary fibrosis: a multi-omics mendelian randomization approach – Nature

August 21, 2024

Enzyme-like nanoparticle–engineered mesenchymal stem cell secreting HGF promotes visualized therapy for idiopathic pulmonary fibrosis in vivo – Science | AAAS

August 13, 2024

Histone deacetylases: potential therapeutic targets for idiopathic pulmonary fibrosis – Frontiers

August 10, 2024

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy – Nature

August 6, 2024

Metabolic profiling of idiopathic pulmonary fibrosis in a mouse model: implications for pathogenesis and biomarker discovery – Frontiers

108 Active Idiopathic Pulmonary Fibrosis Clinical Trials

As of April 1, 2025

Source: clinicaltrials.gov

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

WHAT IS

CONGRESS DOING?